Cholera toxin chimera and its use as a staph vaccine
AssigneeBoise State University
InventorJuliette Tinker
Life of this patent
Estimating the term…
Abstract
The present invention relates to chimeric protein vaccines and methods of use thereof in the treatment of Staphylococcus aureus. One embodiment of the present invention provides a method of generating an immune response in a mammal, that includes administering to the mammal, a composition having a chimeric protein having at least one of: a portion of a cholera toxin, a portion of a heat-labile toxin, and a portion of a shiga toxin; and an antigen having at least one of: an antigenic material from S. aureus and an antigenic material from a S. aureus-specific polypeptide.
Claims10
A chimeric protein capable of generating an immune response in a mammal comprising:
- a truncated clumping factor A (ClfA) protein of Staphylococcus aureus consisting of amino acids 287-559 of SEQ ID NO:
- 25 and
- an adjuvant protein, wherein said adjuvant protein is cholera toxin subunit A (CTA), cholera toxin subunit B (CTB), heat labile toxin subunit B, or Shiga toxin subunit B.
Dependencies are inferred from the claim text.